Similar Search Results

Health insurance and diversity of treatment : a policy mix perspective

Bardey, David; Jullien, Bruno; Lozachmeur, Jean-Marie - 2013

We determine the optimal health policy mix when the average utility of patients increases with the supply of drugs available in a therapeutic class. Health risk coverage rely on two instruments, copayment and reference pricing, that affect the supported risk composed by health expenses and...

Persistent link: https://www.econbiz.de/10009707634

Health Insurance and Diversity of Treatment : A Policy Mix Perspective

Bardey, David - 2013

Persistent link: https://www.econbiz.de/10013086413

Effects of China's Pharmaceutical Price Regulation between 1997 and 2008

Wu, Binzhen - 2014

This paper uses macro-level data between 1997 and 2008 to evaluate the effects of China's pharmaceutical price regulations. We find that these regulations had short-run effects on medicine price indices, reducing them by less than 0.5 percentage points. The effects could have been slightly...

Persistent link: https://www.econbiz.de/10013066440

The Effect of RCTs on Demand for Off-Label Cancer Drugs

McKibbin, Rebecca Jay - 2020

setting of off-label prescribing, where it is possible to observe demand for a drug for a particular cancer both before and … off-label uses of a drug. Using variation in the timing of RCTs across off-label uses of drugs, the results show that … demand for an off-label use of a drug increases on average by 85% if the RCT for that use of the drug shows a statistically …

Persistent link: https://www.econbiz.de/10012837163

State Pharmaceutical Importation Programs : An Analysis of the Cost Effectiveness

Acri née Lybecker, Kristina M.L. - 2019

West Virginia aims to reduce spending on pharmaceuticals by importing them from Canada. To examine the cost effectiveness …

Persistent link: https://www.econbiz.de/10012868596

Impact of parallel trade on pharmaceutical firm’s profits : rise or fall?

Hu, Bin - 2019

, depending on its bargaining power in the price negotiation and market size of the drug. Changes in social welfare due to the …

Persistent link: https://www.econbiz.de/10012871310

Price Regulation and Parallel Imports of Pharmaceuticals

Brekke, Kurt Richard - 2015

This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. In a theory model where the producer price is subject to bargaining between the brand-name producer and a distributor, we show that the effects of stricter price regulation crucially...

Persistent link: https://www.econbiz.de/10013017702

Reference Pricing with Endogenous Generic Entry

Brekke, Kurt Richard - 2015

In this paper we study the effect of reference pricing on pharmaceutical prices and expenditures when generic entry is endogenously determined. We develop a Salop-type model where a brand-name producer competes with generic producers in terms of prices. In the market there are two types of...

Persistent link: https://www.econbiz.de/10013024341

The Dynamics of Pharmaceutical Regulation and R&D Investments

Levaggi, Rosella - 2013

The paper uses a real option approach to investigate the impact of performance-based risk-sharing agreements for the reimbursement of new drugs in comparison with standard cost-effectiveness thresholds. The results show that the exact definition of the risk-sharing agreement is key in...

Persistent link: https://www.econbiz.de/10013078145

Price Regulation and Parallel Imports of Pharmaceuticals

Brekke, Kurt Richard - 2014

This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. First, we develop a theory model in which a pharmacy negotiates producer prices with a brand-name firm and then sets retail prices. We show that the effects of price regulation...

Persistent link: https://www.econbiz.de/10013060442